The policy dividend of promoting the development of medicine and medical industry has been promulgated successively

Absrtact: With the deepening of health reform, the policy dividend of promoting the development of medical medicine industry has been promulgated successively. Recently, the private hospital medical services price loosening of the positive just released, the field of pharmaceutical and electrical business has been good news. Recently, the State administration of Food and Drug Administration

With the deepening of medical reform, the policy dividend to promote the development of pharmaceutical medicine industry has been introduced successively. Recently, the private hospital medical services price loosening of the positive just released, the field of pharmaceutical and electrical business has been good news. Recently, the State administration of Food and Drug Administration related to Guangdong research and development of medical and pharmaceutical regulatory issues, said that the policy will be formulated to support the optimization of Internet medicine sales. In the listed companies, the distribution of pharmaceutical and electrical business is also accelerated, such as SIG pharmaceutical business recently won the license, and Kyushu Tong under the good pharmacist has officially launched O2O business, accelerate the Nuggets medicine E-commerce.

Recently, the state Food and Drug Administration deputy director Yin to Guangdong to investigate the supervision and development of pharmaceutical manufacturers. During the research, Yin revealed: "The research includes opening some of the prescription drug online sales, as soon as possible to determine the online sales of prescription drugs catalogue and standards, as well as the Internet health care consumption method, next, will formulate policies to support the optimization of Internet medicine sales." ”

In recent years, the rapid development of pharmaceutical companies in the process of frequent policy, industry multiple constraints. As the drug as a special commodity, its circulation by the State strict control, sales channels are monopolized by medical institutions, and online purchase of drugs exist trust system and drug safety and many other problems. At the same time, the online pharmacy sales system can not be effectively docked with the medical insurance reimbursement system, but also become an important factor restricting the development of the online pharmacy.

In this regard, some analysts said that the state authorities are considering the gradual increase in the support of pharmaceutical manufacturers, the recent intensive holding of relevant research and research activities, pharmaceutical and electrical business policy adjustment is ready to be. Once the policy is untied, there will be tremendous development opportunities for the pharmaceutical and electronic business.

According to the latest statistics of China Pharmacy and Pharmaceutical Research Center, 2013 China's pharmaceutical electronic transactions amounted to 4.26 billion yuan, compared with 2012 1.6 billion yuan, an increase of 166%. Among them, the day Cat Medical Museum transactions amounted to 2.04 billion yuan, accounted for 47.89%, an increase of 172% per cent, the autonomous pharmaceutical business of the Web site transactions of 1.68 billion yuan, accounting for 39.44%, the year-on-year increase of 98%. We can see that China's pharmaceutical e-commerce is growing rapidly.

In this context, listed companies are also frequently shot to actively layout the pharmaceutical business. Yesterday, Sig Pharmaceutical Bulletin said, the company's wholly-owned subsidiary of Guangdong Kang-Mei Love large pharmacy Chain Co., Ltd. obtained "Internet Drug trading Service Qualification Certificate", its website name is Kang Mei Love, the scope of service is mainly to provide consumers with drugs. With the company to win the pharmaceutical business license plate, SIG pharmaceutical industry to E-commerce platform as the core strategic deployment is becoming better.

At the same time, the reporter learned yesterday, Kyushu Tong under the good Pharmacist Network has officially started O2O business, the early stage will be a first-tier city for the pilot operation. It is worth mentioning that last April, the good pharmacist Day cat shop on the line for Kyushu Tong opened the new situation.

Before, to the day Cat Medicine Hall as the representative of the pharmaceutical electric business platform has been developed in full swing, including Mayinglong, Baiyun Mountain, Yunnan White powder, Tongren, Donga donkey-hide gelatin, nine cheese Hall, Shanghai medicine, including dozens of listed pharmaceutical products have appeared on the online sales platform.

And in this Monday, with Hong Kong securities Citic 21st Century's equity acquisition scheme eventually passed by 96.46% high votes, Ma Yun's medical Shangmeng also officially "landed." January 23, Alibaba announced the joint Yunfeng Fund, announced the acquisition of Citic 21st century 54.3% shares. The industry generally believes that Citic 21st century hands "third-party online drug trading license", to help Ali and the cat in the third party drug sales market to seize the initiative, which is the core of Ma Yun's equity acquisition.

Relevant listed companies have been in a hurry to layout

SIG Pharmaceutical: The company recently won the Pharmaceutical business license, the company's wholly-owned subsidiary of Guangdong Kang Mei Love large pharmacy Chain Co., Ltd. obtained "Internet Drug trading Service Qualification Certificate", its website name is Kang Mei Love, the scope of service is mainly to provide personal medicine to consumers. With the company to win the pharmaceutical business license plate, SIG pharmaceutical industry to E-commerce platform as the core strategic deployment is becoming better.

Kyushu Tong: Its good pharmacists have also officially started O2O business, accelerate the Nuggets medicine E-commerce. Early stage will be a first-tier city for the pilot operation. Last April, a good pharmacist day cat shop on the line for Kyushu opened the new situation.

Chinese Medicine shares: The company is the National Drug Administration identified 41 drugs nationwide retail chain pilot enterprises, 8 drug E-commerce pilot Enterprises.

Harbin Pharmaceutical shares: is a national brand general drug company, pharmaceutical Business Network perfect: With more than 1000 chain pharmacies, pure sales, wholesale, retail business accounts for about 80% of Harbin, 66%, 76%, is the only one with the province coverage capacity of commercial companies, and is expected to further expand in the Northeast region.